Key points are not available for this paper at this time.
Sixty-four children with resectable forms of Wilms's tumor, 12 months of age or older, were selected at random for treatment either with a single course of dactinomycin or to maintenance dactinomycin therapy given intermittently for 15 months in addition to postoperative radiotherapy. Twenty-two patients in one group and 23 in the other were acceptable for evaluation of treatment. Eighty-six per cent of the subjects (19 of 22) given maintenance chemotherapy have had no recurrence to date as compared to 48 per cent (11/23) without recurrence in the group given a single course of dactinomycin. This difference is statistically significant. Toxicity from dactinomycin in the dosage used has been minimal despite concurrent radiotherapy.
Wolff et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: